|Articles|May 5, 2003
Alcon reports findings of two moxifloxacin studies
Alcon Laboratories announced the results of two clinical studies on itsfourth-generation fluoroquinolone moxifloxacin (Vigamox). The results werepresented in a Monday morning poster session.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement















